X4 Pharma (XFOR) Targets 44% Annual Growth as Analysts See Upside
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is a late-stage clinical biopharmaceutical company founded with a mission to develop innovative therapies…
Browsing Tag